EADO - European Association of Dermato-Oncology

Startseite
Schweiz
Zürich
EADO - European Association of Dermato-Oncology

The EADO is a non-profit association dedicated to promote, coordinate and improve clinical and labor

01/04/2026

Prof. Dr. Josep Malvehy, President of the European Association of Dermato-Oncology (EADO) and Professor at the Hospital Clinic de Barcelona, shares the latest from the Board Meeting help on November 2025 in Rome🎓✨

In this video, Prof. Malvehy discusses the impactful work of EADO’s working groups, including:

✅ Updated clinical guidelines for cutaneous squamous-cell carcinomas.
✅ Progress in innovative therapies and clinical trials.
✅ Collaborative efforts for equitable access to skin cancer care across Europe.
✅ New campaigns with .international to tackle fake news in social media.

Why join EADO? Prof. Malvehy highlights the numerous opportunities for professional growth, including educational programs, fellowships, and the chance to collaborate with talented experts in the field. 🤝🌍

👉Stay informed and inspired! Don’t miss our next big event: the 22nd EADO Congress in Prague, April 23-25, 2026. 🇨🇿

Learn more and join the community at eado.org! 🔗

25/02/2026

The European Association of Dermato-Oncology (EADO) is proud to launch a new educational initiative designed to prepare the next generation of leaders in dermato-oncology.

In 2026, 20–30 outstanding young dermatologists will be selected for an intensive one-day Leadership Preceptorship hosted at three prestigious European Skin Cancer Centers in Rome, Barcelona, and Essen.

This highly selective program offers focused training, mentorship from renowned experts, and direct exposure to excellence in clinical and academic dermato-oncology.

🗓️ Application period: February 16 – March 27, 2026
📍 Course dates: May–June 2026
🎓 Certificate of Achievement awarded upon completion

Selection is based on scientific merit, clinical achievements, and leadership potential.
If you are ready to shape the future of skin cancer care in Europe, we encourage you to apply via the EADO website.

16/02/2026

🏛️ EADO Board Meeting Highlights: Advancing cSCC Clinical Guidelines
During the EADO Board Meeting in Rome held in November 2025, critical updates to the treatment landscape for Cutaneous Squamous Cell Carcinoma (cSCC) have been finalized.

Prof. Dr. Christoph Höller (Medical University of Vienna - ) provides an overview of the key clinical developments discussed:

• Adjuvant Therapy: Analysis of the C-POST Trial data regarding Adjuvant Cemplimab and its efficacy in improving disease-free survival.

• Neo-Adjuvant Approaches: The emerging role of immunotherapy in the neo-adjuvant setting for cSCC.

• Rare Skin Tumors: EADO’s new initiative to establish standardized guidelines for rare skin malignancies, addressing current gaps in clinical data.

📅 Save the Date: EADO 2026 in Prague
We invite the global dermato-oncology community to join us for further in-depth discussions at the 22nd EADO Congress.
• Dates: 23 – 25 April 2026
• Location: Prague, Czech Republic

🌎Stay at the forefront of skin cancer research and clinical practice. We look forward to seeing you there to continue advancing science in the field of skin cancer.

🔗 Registration details and the full scientific program are available via the LINK IN BIO. 👈

03/02/2026

Scientific Advancements and Clinical Tools: Insights from Rome
During the EADO Brainstorming Meeting in Rome, the EADO Board advanced several key initiatives aimed at Improving skin cancer management across Europe. Prof. Dr. Lidija Kandolf (Belgrade, Serbia) provides an update on the latest clinical guidelines and digital resources now available to the dermatological community.

Key Updates:
• New Guidelines: The EADO Board has nearly finalized the clinical guidelines for Cutaneous Squamous Cell Carcinoma and initiated a dedicated project for Rare Cancers.

• EADO Website Tools: To support daily clinical practice, particularly for early-career researchers and clinicians, the EADO website offers the EADO Navigator, risk calculators, nomograms, and staging tools for various skin cancers.

Upcoming: 22nd EADO Congress in Prague
We invite you to join the global dermato-oncology community at the 22nd EADO Congress, taking place in Prague from April 23–25, 2026.

👉LINK IN BIO.

16/01/2026

⏰ Good news for researchers and clinicians!
The abstract submission deadline for the 22nd EADO Congress has been officially postponed. You now have extra time to prepare and submit your work.

📅 New deadline: 29 January 2026

This is a valuable opportunity to:
• Present your research at a well-established international meeting
• Share your data with the global dermato-oncology community
• Contribute to high-level scientific discussion in Prague (23–25 April 2026)

If you were close to submitting — or needed a bit more time — now is the moment.

👉 Submit your abstract via the link in bio
We look forward to receiving your contributions and welcoming you to EADO 2026.

24/12/2025

🎄 Season’s Greetings from EADO 2026 🎄
We would like to wish our global dermato-oncology community a joyful Christmas and a peaceful start to the New Year.

The 22nd EADO Congress, taking place in Prague from 23–25 April 2026, is steadily approaching and will once again serve as a key international platform for education, scientific exchange, and collaboration in melanoma and skin cancer.

With a comprehensive scientific program and leading experts from around the world, EADO 2026 aims to foster meaningful dialogue and advance clinical practice and research.

✨ Important reminder before the holidays:
📌 Abstract submission deadline: 15 January 2026
📌 Early Bird registration deadline: 15 January 2026

Submitting your abstract is a great opportunity to showcase your work, while early registration allows you to secure your place at a reduced fee.

🎁 We look forward to welcoming you to Prague in the spring.
Until then, thank you for being part of the EADO community—and enjoy a warm and restful festive season.

19/12/2025

Join the Global Leaders in Dermato-Oncology! 🌍✨
Why should you join EADO? Prof. Dr. Josep Malvehy, President of the European Association of Dermato-Oncology, shares the many reasons why this is the essential “umbrella” for skin cancer professionals worldwid:

“… you will find a lot of networking, a lot of education programs, a lot of science to share. EADO is expanding every year and covers all the fields of skin cancer—from prevention and detection to education and research...”

📍 Save the Date: EADO 2026 Meeting in Prague!
The 22nd EADO Congress is heading to the beautiful city of Prague! Join over 1,000 participants for the world’s leading meeting in dermato-oncology.

• When: 23–25 April 2026
• Where: O₂ universum, Prague, Czech Republic
• Website: eado2026.com

⚠️ ACT FAST! Early Bird tickets are available for a very limited time. Secure the best rate before the deadline on 15 January 2026.

Don’t miss out on:
✅ Cutting-edge science and research
✅ Global networking opportunities
✅ Specialized task forces on biomarkers and new therapies

🔗 Register now & join the community: Link in Bio!

12/12/2025

Prof. Dr. Giovanni Pellacani (), President of SIDeMaST ( - the Italian Society of Dermatology and Sexually Transmitted Diseases) Full Professor of Dermatology at Sapienza University of Rome (), as well as Director of the Dermatology Unit at Policlinico Umberto I .umberto1 — shares his wisdom with the next generation of dermato-oncologists. 👨‍⚕️📚

He encourages young clinicians to do what they love, innovate boldly, and always keep the patient at the heart of their work.

20/11/2025

Prof. Dr. Jeffrey Gershenwald (, Houston) highlighted ongoing international efforts to update and refine the Melanoma Staging System.

During a session co-chaired with Prof. David Elder (University of Pennsylvania), key topics included:

– The debate around melanoma overdiagnosis and its implications for clinical practice
– Advances in AI-driven melanoma classification, presented by Dr. Allan Halpern
– The need to build a revitalized global melanoma database to inform future revisions of the AJCC staging system

📢 Prof. Gershenwald invites centers worldwide — especially across Europe — to contribute high-quality melanoma datasets to help shape the next generation of evidence-based staging.

📍Stay tuned for updates, and join us in Prague for EADO 2026 to learn more.

12/11/2025

In Part 2 of his conversation, Prof. Dr. Josep Malvehy, President of the EADO and Director at Hospital Clínic Barcelona, expands on how AI and natural language tools are reshaping the future of dermato-oncology.

🧠 From analyzing vast datasets in minutes to creating AI-generated control groups for clinical studies, these technologies are revolutionizing both research design and daily decision-making.

📊 As Prof. Malvehy reminds us — whether you’re a young doctor or an experienced clinician — understanding and integrating AI tools will soon be essential for advancing precision care in dermatology and oncology.

📍Stay tuned for more insights on how innovation meets clinical practice.

👉See you at the 22nd EADO Meeting 2026 in Prague. LINK IN BIO 🔗

07/11/2025

In this conversation, Prof. Dr. Josep Malvehy, President of the EADO and Director at Hospital Clínic Barcelona, shares his perspective on how AI technologies are reshaping dermatology and skin cancer care.

🧠 “AI doesn’t replace your knowledge — it complements it.”
From 2D and 3D total body imaging to advanced analytics and natural language tools, AI is becoming a valuable ally for clinicians, supporting diagnostics, research, and patient management.

💡 As Prof. Malvehy highlights, understanding how to interpret and apply AI-generated insights is key: knowing when it helps — and when it doesn’t — will define the next generation of clinical excellence.

📍Follow for Part 2 to explore how AI and real-world data are shaping the future of dermato-oncology.

06/10/2025

At , Prof. Dr. Swen Malte John (University of Osnabrück, Chair of the EADV Task Force on Occupational Skin Diseases) highlighted the outcomes of the 4th Multi-Stakeholder Summit on Occupational Skin Cancer, made possible by the EADO.

👥 This important summit brought together representatives from the Ministry of Health of Greece, the International Labour Organization (ILO), and the World Health Organization (WHO).

📌 The main objective: to advance recognition of skin cancer as an occupational disease, especially for outdoor workers frequently exposed to the sun. Strengthening prevention and policy efforts can significantly improve worker health worldwide.

📍The discussion continues at EADO 2026 in Prague [LINK IN BIO]

Adresse

Max-Högger-Strasse 6
Zürich
8048

Webseite

http://www.eado.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von EADO - European Association of Dermato-Oncology erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.